1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with pinacidil in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (pinacidil) | Trials (pinacidil) | Recent Studies (post-2010) (pinacidil) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 1,059 | 41 | 125 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crystal, GJ; Hu, G; Salem, MR; Vinten-Johansen, J; Zhao, ZQ | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and pinacidil
| Article | Year |
|---|---|
Isoflurane inhibits neutrophil-endothelium interactions in the coronary circulation: lack of a role for adenosine triphosphate-sensitive potassium channels.
Topics: Acetylcholine; Adenosine Triphosphate; Anesthetics, Inhalation; Animals; Arteries; Cell Adhesion; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Endothelium, Vascular; Glyburide; In Vitro Techniques; Isoflurane; Neutrophil Activation; Neutrophils; Nitroprusside; Pinacidil; Platelet Activating Factor; Potassium Channel Blockers; Potassium Channels; Superoxides; Vasoconstriction; Vasodilation; Vasodilator Agents | 2002 |